Trial · NCT05810948
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline to week 24 in urine protein creatinine ratio (UPCR) | up to 24 weeks | |
| Secondary | Proportion of participants achieving complete renal response (CRR) at week 24 | up to 24 weeks | |
| Secondary | Time to complete renal response (CRR) | up to 32 weeks | |
| Secondary | Proportion of participants achieving partial renal response at week 24 | up to 24 weeks | |
| Secondary | Time to partial renal response (PRR) | up to 24 weeks | |
| Secondary | Change from baseline to week 24 in estimated glomerular filtration rate (eGFR) | up to 24 weeks | |
| Secondary | Change from baseline to week 24 in Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)-2K score | up to 24 weeks | |
| Secondary | Change from baseline to week 24 in the dosage of glucocorticoids | up to 24 weeks | |
| Secondary | Treatment failure rate during treatment period | up to 24 weeks | |
| Secondary | Proportion of participants achieving modified complete renal response (mCRR) at week 24 | up to 24 weeks | |
| Secondary | Efgartigimod serum concentration-time profile | up to 32 weeks | |
| Secondary | Changes from baseline in levels of total IgG | up to 32 weeks | |
| Secondary | Incidence of ADA against efgartigimod | up to 32 weeks | |
| Secondary | Median changes in concentration from baseline over time in biomarkers (Anti-dsDNA, C3, C4 and CH50) | up to 32 weeks | (all have the same measuring units) |
| Secondary | Change from baseline to week 24 in EuroQoL 5-Dimension 5-Level (EQ-5D-5L) score | Up to 24 weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05810948/registered